Københavns Universitet
Records under this name other than the patents Københavns Universitet holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.
Back to Københavns Universitet
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,100,100 | Metallothionein-derived peptide fragments Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,518,089 | Metallothionein-derived peptide fragments Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,912,311 | Generation of a Cancer-Specific Immune Response Toward MUC1 and Cancer Specific MUC1 Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 10,919,973 | Generation of a Cancer-Specific Immune Response Toward MUC1 and Cancer Specific MUC1 Antibodies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,618,060 | Metallothionein-derived peptide fragments Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,573,984 | Chimeric Inhibitor Molecules of Complement Activation Formerly held In force · High confidence | In force | High confidence | |
| US 9,815,876 | Chimeric Inhibitor Molecules of Complement Activation Formerly held In force · High confidence | In force | High confidence | |
| US 10,752,661 | Chimeric Inhibitor Molecules of Complement Activation Formerly held In force · High confidence | In force | High confidence | |
| US 9,382,517 | HCV full-length infectious cell culture systems and applications thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,790,184 | Inhibitors of Histone Deacetylase Formerly held In force · High confidence | In force | High confidence |